Has Katelyn Kopcsay, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,354 in general payments to Katelyn Kopcsay, MD across 28 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Katelyn Kopcsay, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Katelyn Kopcsay, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Katelyn Kopcsay, MD

Urogynecology and Reconstructive Pelvic Surgery · Springfield, MANPI 1497069595

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. Coloplast accounts for 88.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $1,486 and has fallen 76.4% since, to $351 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in MA, where the typical reported total is $2,944.

$3,354in general payments, 2019–2025

Across 28 payments — averaging $119.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Coloplast$3K
Boston Scientific$182
AbbVie$107
Applied Medical Resources Corporation$66
Olympus America Inc.$20

$5,339in research payments, 2019–2025

Across 1 payment — averaging $5338.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Coloplast$5K

What the payments were for

Travel & lodging$1,22336%
Food & beverage$1,99960%
Education$1324%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Coloplast	21	$2,978
Boston Scientific	3	$182
AbbVie	2	$107
Applied Medical Resources Corporation	1	$66
Olympus America Inc.	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ALTIS$1,485
Solyx SIS System$125

How this compares

$3,354 in reported general payments places this provider in the 50th percentile of 35 urogynecology and reconstructive pelvic surgery providers in Massachusetts.

See all urogynecology and reconstructive pelvic surgery providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$115,424

Medicare patients

144

Services billed

4,719

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
GemtesaVibegron	83	$80,130
MyrbetriqMirabegron	54	$34,074
Estradiol	59	$4,746
Mirabegron ErMirabegron	11	$2,482
Clobetasol Propionate	15	$348
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	33	$304
Ibuprofen	67	$281
Oxycodone Hcl	76	$130
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	33	$34

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Springfield

Keisha JonesSpringfield$3K
Elliot GreenbergSpringfield$866
Ellen SolomonSpringfield$765
Deepali MaheshwariSpringfield$608
Diego IllanesMilford$277K
Peter RosenblattCambridge$223K
Eman ElkadryCambridge$130K
Amos AdelowoWorcester$30K
Lori JonesBoston$22K
William WinkelmanCambridge$16K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →